Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520 (NCT03657381) | Shandong New Time Pharmaceutical Co., LTD | 2019-03-01 |
Track Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.